Lamy, O

Kanis, J A; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2023). Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporosis international, 34(12), pp. 2027-2045. Springer-Verlag 10.1007/s00198-023-06870-z

Vandenput, L; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2022). Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporosis international, 33(10), pp. 2103-2136. Springer-Verlag 10.1007/s00198-022-06435-6

Biver, E; Calmy, A; Aubry-Rozier, B; Birkhäuser, M; Bischoff-Ferrari, H A; Ferrari, S; Frey, D; Kressig, R W; Lamy, O; Lippuner, Kurt; Suhm, N; Meier, C (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporosis international, 30(5), pp. 1125-1135. Springer-Verlag 10.1007/s00198-018-4794-0

Lippuner, Kurt; Buchard, P A; De Geyter, C; Imthurn, B; Lamy, O; Litschgi, M; Luzuy, F; Schiessl, K; Stute, P; Birkhäuser, M (2012). Recommendations for raloxifene use in daily clinical practice in the Swiss setting. European spine journal, 21(12), pp. 2407-17. Berlin: Springer-Verlag 10.1007/s00586-012-2404-y

Rizzoli, R; Kraenzlin, M; Krieg, M A; Mellinghoff, H U; Lamy, O; Lippuner, K (2011). Indications to teriparatide treatment in patients with osteoporosis. Swiss medical weekly, 141, w13297. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13297